ChemoMetec A/S affirmed earnings guidance for the fiscal year 2022/2023. For the year, based on developments in the third quarter of 2022/23, guidance for financial year 2022/23, as announced in connection with the release of the interim report for 2022/23 on 8 February 2023, is maintained. Accordingly, revenue for 2022/23 is expected in the range of DKK 430 million - DKK 460 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
312.8 DKK | -0.64% | +7.86% | -19.38% |
04-12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
04-12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.38% | 786M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
-5.53% | 5.33B | |
+42.58% | 5.1B | |
-32.61% | 2.54B | |
+10.80% | 1.99B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023